Welcome to PALS!
The Psychopathology and Allostatic load across the Life Span (PALS) network is a network of international academic centers that have come together to transform windows of vulnerability to mental and physical disorders into windows of neuroscientific advancement with diagnostic and therapeutic implications.
To view the full mission statement, click here. To learn more about the aims and goals of PALS, the different academic sites, and current events and projects, please explore the tabs located in the sidebar.
Recent Publications
March 2018 - Congratulations to Drs. Doucet, Frangou, and Rasgon for
"Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis," recently published in JAMA Psychiatry.
"Alterations in multiple neuroimaging phenotypes have been reported in psychotic disorders. However, neuroimaging masures can be influenced by factors that are not directly related to psychosis and may confound the interpretation of case-control differences. Therefore, a detailed characterization of the contribution of these factors to neuroimaging phenotypes in psychosis is warranted."
Click here to read the full paper!
March 2018 - Congratulations to Dr. Singh and Dr. Rasgon for "Brain and behavioral correlates of insulin resistance in youth with
depression and obesity" in press in Hormones and Behaviors.
"We posit that, in the context of depressive symptoms, insulin resistance is associated
with aberrant structure and functional connectivity in the Anterior Cingulate Cortex (ACC) and hippocampus."
Announcements:
March 2018: Drs. Rasgon, Reagan, Tamashiro, and Nasca recently received a grant from the Pritzer Consortium to conduct research on gestational diabetes. This is the first PALS-wide grant to receive funding, so congratulations to all!
Click here to learn more about the Pritzker Consortium
Recent Events:
March 2018: Drs. Felice and Reagan presented at the Plenary Symposia for the American Society of Neurochemistry meeting in Riverside. Their symposium was entitled "Insulin Resistance, Cognitive Dysfunction and Depression: A common triad in Alzheimer's disease."
Meet the Members!
Print 